Overview
What is Allosource?
Allosource is a nonprofit organization based in Centennial, Colorado, with a team of 609 employees. They specialize in processing and distributing donated human tissue, advancing patient healing through innovative cellular and tissue allografts. In 2022, they processed over 8,600 donors and distributed the tissue throughout North America, South America, Central America, the Caribbean, Europe, the Middle East, Asia, and Oceania. Musculoskeletal and soft tissue donors offer opportunities to create life-saving and life-enhancing solutions for orthopedic, spine, burn, and wound procedures. Accredited by the American Association of Tissue Banks and registered with the FDA, Allosource is committed to responsibly providing these essential tissue solutions.
Official website here: www.allosource.org/
Is Allosource legitimate?
Allosource is a legitimate nonprofit organization registered as a 501(c)(3) entity. Allosource submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $3,664,730
Professional Fundraising Fees: $0
Other Salaries and Wages: $37,212,896
For more financial information, click here
Official website here: www.allosource.org/
What is the mission statement of Allosource?
Allosource is inspired by the generosity of donors in their community, and they are dedicated to responsibly providing innovative cellular and tissue allografts to advance patient healing. In 2022, they processed over 8,600 donors' tissue and distributed it throughout North America, South America, Central America, Caribbean, Europe, Middle East, Asia, and Oceania. Musculoskeletal and soft tissue donors provide the opportunity to create life-saving and life-enhancing solutions in various procedures, such as orthopedic, spine, burn, and wound procedures. Allosource's commitment to patient health and mobility is reflected in their accreditation by the American Association of Tissue Banks and registration with the FDA.
Official website here: www.allosource.org/
What is the revenue of Allosource?
Who are the executives of Allosource and what are their salaries?
The average compensation at Allosource during 2022 was $67,123. There are 609 employees and 5 volunteers at Allosource.
Here are 20 key members and their salaries (Allosource's CEO's salary is $825,722 and their total compensation is $984,947):
- Thomas A Cycyota (President, Ceo) [Trustee/Director]
- Dean H Elliott (Chief Operating Officer)
- Hannis W Thompson Iii (Medical Director)
- Yan Deng (Chief Financial Officer)
- Kevin L Whitten (Chief Commercial Officer)
- Brian R Bobka (Vp International)
- Kenneth Hammons (Svp Operations)
- Corey Stone (Executive Director Essent Biologics)
- Kimberly Meyer (Svp Quality & Performance Excellence)
- John Lafakis (Area Manager)
- Inga Gurevich (Associate Medical Director)
- Michelle Zeppelin (Vp Human Resources)
- Matthew Ozment (Regional Accounts Manager - Plastics)
- Raphael Diaz (Vp Sales)
- Alan Okerman (Director It)
- Diane Brockmeier (Board Member - Chair) [Trustee/Director]
- Jennifer Prinz (Board Member - Treasurer) [Trustee/Director]
- Dr Harry Wilkins (Board Member) [Trustee/Director]
- Mark Simon (Board Member) [Trustee/Director]
- Suzanne Conrad (Board Member) [Trustee/Director]
Official website here: www.allosource.org/
Where can I find the form 990 for Allosource?
The Allosource’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.allosource.org/
Learn more at the official website: www.allosource.org/
Mission Statement of Allosource
Allosource, a leading organization in human donated tissue processing and distribution, is dedicated to enhancing and saving lives through innovative cellular and tissue allografts. Inspired by the generosity of donor communities, Allosource responsibly provides life-saving and life-enhancing solutions to advance patient healing.
In 2022, Allosource fulfilled this mission by processing over 8,600 donors and distributing their tissue throughout North America, South America, Central America, the Caribbean, Europe, the Middle East, Asia, and Oceania. Musculoskeletal and soft tissue donors offer a valuable opportunity for Allosource to create life-saving and life-enhancing solutions in various medical procedures, including orthopedic, spine, burn, and wound treatments. These allografts play a crucial role in restoring patient health and mobility.
Allosource's commitment to providing innovative cellular and tissue allografts is backed by its accreditation by the American Association of Tissue Banks and registration with the Food and Drug Administration. This dedication to maintaining the highest standards ensures the safety and effectiveness of the tissue donations, ultimately allowing Allosource to fulfill its mission and make a positive impact on countless lives.
Impact
This information is meant to be a general summary of Allosource. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Allosource's impact lies in responsibly processing and distributing human donated tissue to enhance and save lives. By processing over 8,600 donors in 2022 and distributing tissue across multiple continents, Allosource plays a crucial role in providing innovative cellular and tissue allografts that advance patient healing. This work enables the creation of life-saving and life-enhancing solutions for various medical procedures, including orthopedic, spine, burn, and wound treatments, ultimately helping to restore patient health and mobility. Allosource's commitment to accreditation and regulation ensures the highest quality standards in their operations, further solidifying their positive impact on global healthcare.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
TISSUE DISTRIBUTION & PROCESSING
Revenue
$156,687,600
Organization Details
Founding Year
1994
Phone
(720) 873-0213
Main Address
6278 S TROY CIRCLE, CENTENNIAL, CO, 80111
Website
www.allosource.org/
NTEE Category
Code: E65 - Health
If you are a representative of Allosource and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.